AstraZeneca Partners with Boston Properties on Cambridge R&D Center
AstraZeneca is partnering with Boston Properties to create a 570,000-sf R&D center in Cambridge’s Kendall Square. Housing approximately 1,850 employees, the 16-story building will offer world-class research environments for the creation of advanced biomedical therapies and vaccines. This nexus of innovation and discovery will feature flexible open laboratories arranged in neighborhoods with shared instrumentation suites and collaboration spaces.